INSIGHTS ON DRUG DEVELOPMENT
-
Remote Measurements For Bulk Samples
Remote Raman spectroscopy enables accurate material identification at long distances without complex focusing. Learn how pathlength, sample properties, and substrate choice impact signal quality.
-
Getting The Most Out Of Cell-Based Assays With The Optimal Read Function
Gain insight into a whole-well fluorescence analysis that improves sensitivity and reproducibility in cell-based assays by accounting for uneven cell distribution.
-
Benchmarking Filtration Performance Of TFF Cassettes
Optimize your protein purification workflow with tangential flow filtration by comparing membrane performance and exploring how protein concentration impacts flux and MWCO selection in lab-scale systems.
-
History Of Peptides In Medicine: From Early Chemistry To The GLP-1 Era
Peptide therapeutics from early chemical breakthroughs to today’s metabolic drugs, highlighting scientific, clinical, and manufacturing advances shaping modern drug development.
-
Process Intensification: Your Guide To "Doing More With Less"8/5/2025
Explore innovative strategies in process intensification to boost mAb production and hear from industry experts as they share solutions for scaling efficiency and navigating regulatory challenges.
-
Efficient mAb Development With A Flexible Purification Toolkit6/4/2026
Increasing mAb complexity is pushing purification beyond traditional platforms. See how flexible chromatography, optimized buffers, and adaptable workflows are becoming essential to achieve target purity.
-
Navigating Nitrosamine Impurities In Pharmaceutical Drug Development3/3/2026
Understanding formation mechanisms and potency categorization allows developers to mitigate risks early, ensuring regulatory compliance and patient safety without compromising product performance.
-
Aggregate Analysis Of Tirzepatide12/11/2025
A new size exclusion method effectively analyzes Tirzepatide aggregates, demonstrating robust separation and reproducibility with minimal need for organic solvents or acidic modifiers.
-
Right From The Start: Smarter Developability For Stronger Formulations2/4/2026
Early developability assessment integrates manufacturability, QbD, flexible formulations, and CDMO support to cut risk, speed development, and enable scalable, robust drugs.
DRUG DEVELOPMENT SOLUTIONS
-
We have developed an innovative portfolio of affinity chromatography resins to help you solve challenges in the downstream process of next-generation antibody therapeutics. These resins are specifically designed for the purification of engineered monoclonal antibody (mAbs) modalities.
-
Explore a range of devices for free fraction analyses and determination of plasma protein binding that make sample preparation easier and faster, with complete phospholipid removal and proven reproducibility.
-
Support high-yield viral vector production with media designed for transfection efficiency, scalability, and reduced aggregation in HEK293 cells, ideal for AAV and LV workflows.
-
Accelerate sterile injectable development with expert support, advanced facilities, and tailored solutions for complex APIs — from formulation through commercialization across small molecules and biologics.
-
Sterility is key for high-risk applications such as injectables, parenteral formulations, ophthalmic and peritoneal dialysis solutions, and many more.